Form 13-F position report

EYEGATE PHARMACEUTICALS INC

Reported by Raymond James Financial Services Advisors Inc

KPHMW CUSIP 30233M107 Manager CIK 0001462284

Reported 0 shares, down 15,000 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q4 2018
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 3 Through Q4 2018

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value

Quarterly position history

How this manager's reported quarter-end position changed over time.

0 quarters
Quarterly reported position history for EYEGATE PHARMACEUTICALS INC held by Raymond James Financial Services Advisors Inc.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
This position's reported history falls outside the five-year preview window. A free account unlocks it. Unlock full history

Who else reported the position

23 managers reported EYEGATE PHARMACEUTICALS INC for Q4 2018.

Managers reporting EYEGATE PHARMACEUTICALS INC in Q4 2018.
Manager Activity Shares Change % of reported 13F Reported value Tenure
ARMISTICE CAPITAL LLC Added 17,262,853 +460,353 0.61% $8,029,000 7 qtrs
VANGUARD GROUP INC Added 131,610 +16,200 < 0.01% $61,000 13 qtrs
PANAGORA ASSET MANAGEMENT INC Added 128,176 +20,746 < 0.01% $60,000 2 qtrs
ACADIAN ASSET MANAGEMENT LLC Added 97,723 +21,700 < 0.01% $46,000 4 qtrs
Virtu Financial LLC New 68,391 +68,391 < 0.01% $32,000 1 qtr
CITADEL ADVISORS LLC Added 48,251 +12,759 < 0.01% $22,000 5 qtrs
US BANCORP DE Unchanged 40,650 0 < 0.01% $19,000 4 qtrs
UBS Group AG New 26,007 +26,007 < 0.01% $12,000 5 qtrs
WEDBUSH SECURITIES INC Unchanged 20,000 0 < 0.01% $9,000 5 qtrs
NORTHERN TRUST CORPORATION Unchanged 14,553 0 < 0.01% $7,000 6 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2018
Filed
February 11, 2019
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.